Investor Presentation on Q1 FY27 Financial Results

29th July, 2026 The General Manager-Department of The Manager-Listing Department, Corporate Services, National Stock Exchange of India Limited, BSE Limited, "Exchange Plaza", 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001. Bandra (East), Mumbai – 400 051. Scrip Code : 530999 Symbol : BALAMINES Dear Sir/Madam, Sub.: Investor Presentation on Q1 FY27 Financial Results Ref.: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Q1 FY27 Financial Results. This Investor Presentation may also be accessed on the website of the Company at https://www.balajiamines.com/investor-relations.php. This is for your kind information and records. Thanking you, Yours faithfully, For Balaji Amines Limited Abhijeet Kothadiya Company Secretary & Compliance Officer Encl.: a/a INDIA FIRST. Building What India Needs Before India Asks for It. BALAJI AMINES LIMITED Investor Presentation | Q1FY27 Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third-party statements and projections. All Maps used in the presentation are not to scale. All data, information, and maps are provided "as is" without warranty or any representation of accuracy, timeliness or completeness. FINANCIAL HIGHLIGHTS Q1FY27 Key Highlights of the Quarter We have commenced FY27 on a strong note, delivering healthy operational and financial performance with resilient margins, supported by improving demand across key end-user industries. Our diversified portfolio, integrated manufacturing platform and strong customer relationships have enabled us to capitalise on operational efficiencies and sustain performance despite global macroeconomic headwinds and the West Asia crisis. During the quarter, we achieved a significant milestone with the commissioning of India's first commercial-scale 100,000 TPA Dimethyl Ether plant - an important step in our vision to diversify into new-age chemicals and alternate fuels, while reinforcing our commitment to import substitution. Our NMM and Acetonitrile expansion projects remain firmly on track for commissioning by the end of the financial year, and the expansion at Balaji Speciality Chemicals Limited is progressing as planned. Backed by a healthy order pipeline, improving demand and Mr. Dundurapu Ram Reddy disciplined execution, we remain confident of delivering sustainable growth in the coming Managing Director years. Financial highlights – Q1 FY27 STANDALONE CONSOLIDATED Total Revenue (INR Cr) EBITDA (INR Cr) Total Revenue (INR Cr) EBITDA (INR Cr) 110 461 94 403 121 370 367 327 102 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 PAT (INR Cr) PAT (INR Cr) EBITDA & PAT MARGIN (%) EBITDA & PAT MARGIN (%) 62 26% 26% 78 25% 26% 20% 65 17% 17% 17% 17% 40 16% 12% 37 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 EBITDA PAT EBITDA PAT Consolidated Statement of Profit & Loss Particulars (Rs.Crs.) Q1FY27 Q1FY26 Y-o-Y Q4FY26 Q-o-Q FY26 Revenue from Operations 456 358 395 1425 Other Income 6 9 8 29 Total Revenue 461 367 25.73% 403 14.64% 1454 Total Raw Material 253 212 221 796 Employee Expenses 26 20 26 84 Other Expenses 61 71 53 279 EBITDA 121 63 91.51% 102 19.03% 294 EBITDA Margin (%) 26% 17% 25% 20% Depreciation 14 14 14 56 EBIT 108 49 117.77% 88 22.24% 238 EBIT Margin (%) 23% 16% 22.3% 13.8% Finance Cost 1 1 2 5 Profit before Tax 106 49 118.14% 86 23.69% 232 Profit before Tax(%) 23% 13% 21% 16% Tax 28 12 21 63 Profit After Tax 78 37 110.19% 65 20.75% 169 PAT Margin (%) 17% 10% 16% 12% EPS (As per Profit after Tax) 23.13 11.73 19.99 51.6 COMPANY OVERVIEW At a Glance One of India’s Largest Aliphatic amines India’s First years of WE BUILT INDIA’s 1st manufacturers manufacturing Commercial DME expertise INDIGENOUS TECHNOLOGY Manufacturer FOR MANUFACTURING Core ALIPHATIC AMINES processes 3,93,600+ Developed MTPA Installed through Capacity Inhouse- R&D Driven by innovation and import substitution, Balaji Amines continues to strengthen its Debt free specialty chemicals portfolio 40+ Standalone through differentiated products and balance sheet Products disciplined expansion. International Countries served clients Corporate Structure 4 Manufacturing 2 Speciality Chemical Units Operations across Locations (BSCL) Maharashtra & Telangana Strong multi-location Focus on High- Value Strategically located for scale manufacturing base Speciality Chemicals and efficiency Balaji Amines Ltd BALAJI SPECIALITY BALAJI AMINES CHEMICALS LTD ( Subsidiary) (Core Manufacturing) Leading manufacturer of aliphatic amines Expanding the portfolio of speciality for high- and speciality chemicals growth industries Hotel Balaji Sarovar Hospitality Division Unit I Unit II Unit III Unit IV BSCL Unit I BSCL Unit II Solapur Telangana Solapur Solapur Solapur Solapur Manufacturing Locations – Built for Scale BALAJI AMINES Unit I – Solapur Unit II – Telangana Unit III – Solapur Unit IV – Solapur Certifications: Key Products: Key Products: • ISO 9001:2015 Key Products: Key Products: • Dimethyl Formamide • Ethyl amines Quality Management Systems • Methylamines • Dimethylamine (DMA), • Morpholine • Methylamines • ISO 14001:2015 • Ethyl amines Hydrochloride (HCl) • Acetonitrile • N-Butylamine Environmental Management • Morpholine • Isopropyl amines (MIPA) • Polyvinylpyrrolid [Showing first 8,000 characters — download PDF for full document]